Work

OLIKOS Study: 6-month Interim Efficacy and Safety in Patients with Relapsing Multiple Sclerosis Who Switched to Subcutaneous Ofatumumab from Intravenous Anti-CD20 Therapies (P10-6.006)

Year: 2024

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.0000000000204967

Authors: Enrique Alvarez, Brandon Brown, Elizabeth Camacho, Benjamin Greenberg, Roland Henry, Rebecca Piccolo, Le Hua

Institutions: Rocky Mountain MS Center, University of Colorado Anschutz, Novartis (United States), The University of Texas Southwestern Medical Center, University of California, San Francisco, Cleveland Clinic, Lou Ruvo Brain Institute

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4394599166

FWCI: 0.298

Cites:

Cited by: 1

Related to: 10